Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: July 2, 2022

Superpharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SUPERPHARM, and what generic and branded alternatives to SUPERPHARM drugs are available?

SUPERPHARM has eighty-eight approved drugs.

Summary for Superpharm

US Patents:	0
Tradenames:	44
Ingredients:	43
NDAs:	88

Drugs and US Patents for Superpharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Superpharm	HYDROXYZINE PAMOATE	hydroxyzine pamoate	CAPSULE;ORAL	089032-001	Jan 2, 1987		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Superpharm	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	088787-001	Aug 28, 1984		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Superpharm	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	088855-001	Nov 13, 1984		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Superpharm	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	088856-001	Nov 13, 1984		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Superpharm	THIORIDAZINE HYDROCHLORIDE	thioridazine hydrochloride	TABLET;ORAL	089104-001	Jul 2, 1985		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

McKesson

Harvard Business School

Medtronic

Mallinckrodt

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.